NPS fund management taps former GEPS CIO Seo as new chief

National Pension Service (NPS) of South Korea, the world's third-largest pension fund, has tapped Seo Won-joo as the new chief investment officer, a...

KT builds hyper-connected R&D network KOREN data site

KT Corp. said on Monday that it will start operation on Jan. 5 after completing the construction of KOREN data lake portal site, which provides vari...

KOICA donates Celltrion's Herzuma to Ukraine

Celltrion Healthcare Co. said on Monday that Herzuma (ingredient name: Trastuzumab) was dispatched to patients in Ukraine by the Korea International...

Hyundai Heavy Industries Group changes its name to HD Hyundai

HD Hyundai held a 50th-anniversary vision declaration ceremony at its Global R&D Center in Seongnam, Gyeonggi Province, on Monday where it annou...

CJ applies to FDA for trials of immuno-anticancer drug candidate

CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...

CJ ENM sets up brand incubator Brandworks Korea

South Korean entertainment powerhouse CJ ENM Co. plans to foster the brand incubating business and promote sales through Brandworks Korea, the compa...

LIG Nex1 signs maritime surveillance radar-II defense contract

LIG Nex1 Co. said on Friday that it has signed an agreement with the Naval Logistics Command for the Maritime Surveillance Radar-II project, which w...

Samsung Elec to develop Vietnam as global strategic base

Samsung Electronics Co., the world’s top memory chip and smartphone maker, aims to nurture Vietnam as a global strategic base as it opens a ne...

LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn

South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...

Dong-A ST incorporates NeuroBo as subsidiary

Dong-A ST said on Friday that it would acquire American drug company NeuroBo Pharmaceuticals as a subsidiary.NeuroBo, located in Boston, is a Nasdaq...

SK Signet to showcase new ultra-fast charger at CES 2023

SK Signet Inc., the No.1 company in the US ultra-high speed charger market, will showcase a new standard ultra-fast charger V2 at CES 2023, the worl...

SK Broadband develops eco-friendly rechargable remote control

South Korea's internet service provider SK Broadband has developed a new B tv remote control that can be recharged with significantly reduced chargi...

Hyundai Heavy develops new chemical-resistant paint for PC carriers

Hyundai Heavy Industries Group said Wednesday that it has developed a paint product for petrochemical product (PC) carriers with significantly impro...

S.Korean biopharmaceutical sector to see brisk M&As in H1, 2023

An expert says the first half of next year will see the start of brisk M&As in biopharmaceuticals targeting strategic investors.Pyeon Jae-seong,...

Hyundai Motor's compact SUV Kona gets bigger

Hyundai Motor Co. on Tuesday unveiled the new design of its compact SUV the new "all-new Kona."The all-new Kona is a second-generation model being i...

Hyundai becomes younger with 1 in 3 new executives in their 40s

South Korea’s Hyundai Motor Group, which owns Hyundai Motor Co. and Kia Corp., has carried out a year-end mid-tier executive reshuffle marked ...

Syntekabio launches new drug development platform STB Cloud in US

Syntekabio,Inc., a South Korean artificial intelligence (AI) drug development company, said on Monday it has launched its cloud-based AI drug develo...

Leaders of Samsung, BMW discuss bolstering EV battery partnership

Samsung Electronics Chairman Jay Y. Lee met with the Chairman of the Management Board of BMW Group Oliver Zipse on Saturday to discuss ways to deepe...

Samsung eyes new mobile AP chip to take on Apple's iPhone

Samsung Electronics Co. and Apple Inc. have had a long rivalry in the global market for smartphones and other mobile devices. In terms of sales...

LG Chem in $95.5 million drug out-licensing deal with China’s Innovent

LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., and China’s biotech company Innovent Biologics have entered into a strategi...

Daewoo Shipbuilding, POSCO jointly develop new materials

South Korea's Daewoo Shipbuilding & Marine Engineering Co. (DSME) and steelmaker POSCO have joined forces to develop new materials.DSME on Wedne...

Helixmith acquires US patent on new freeze-dried formulation

South Korea's biotech company Helixmith Co. said Wednesday it has developed and patented a new freeze-dried formulation for Engensis (VM202), a non-...

Daewoong submits new drug applications for Fexuclue in 10 countries

South Korea's leading drug company Daewoong Pharmaceutical is accelerating its global expansion efforts for its 34th domestically developed drug Fex...

SK C&C to automate production process of SKC's US subsidiary

SK C&C announced on Wednesday that it will start a project to install a full-process automation system based on its smart factory platform I-FAC...

CJ Logistics expands global e-commerce shipping services

South Korea’s CJ Logistics Corp. is ramping up its cross-border e-commerce (CBE) businesses as its local rival Coupang Inc. is increasing domi...

S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug

South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...

LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials

LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...

LG Group seeks future growth engines with new R&D units

LG Group, South Korea’s fourth-largest conglomerate, set up new research and development units at key affiliates to seek future growth engines...

South Korea passes new law making everyone a little younger

SEOUL—As the rest of the world ages, South Koreans are getting younger.South Korea’s parliament passed laws Thursday abolishing the trad...

New drug developer Onconic Therapeutics raises $20 mn in Series B

South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...